ATE126796T1 - Quinazolinderivate und ihre herstellung. - Google Patents

Quinazolinderivate und ihre herstellung.

Info

Publication number
ATE126796T1
ATE126796T1 AT90123876T AT90123876T ATE126796T1 AT E126796 T1 ATE126796 T1 AT E126796T1 AT 90123876 T AT90123876 T AT 90123876T AT 90123876 T AT90123876 T AT 90123876T AT E126796 T1 ATE126796 T1 AT E126796T1
Authority
AT
Austria
Prior art keywords
alkyl
hydroxy
protected
heterocyclic
production
Prior art date
Application number
AT90123876T
Other languages
English (en)
Inventor
Shimazaki Norihiko
Yamazaki Hitoshi
Yatabe Takumi
Tanaka Hirokazu
Itoh Yoshikuni
Hashimoto Masashi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909000014A external-priority patent/GB9000014D0/en
Priority claimed from GB909025065A external-priority patent/GB9025065D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE126796T1 publication Critical patent/ATE126796T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90123876T 1990-01-02 1990-12-12 Quinazolinderivate und ihre herstellung. ATE126796T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909000014A GB9000014D0 (en) 1990-01-02 1990-01-02 Quinazoline derivatives and their preparation
GB909025065A GB9025065D0 (en) 1990-11-19 1990-11-19 Quinazoline derivatives and their preparation

Publications (1)

Publication Number Publication Date
ATE126796T1 true ATE126796T1 (de) 1995-09-15

Family

ID=26296447

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90123876T ATE126796T1 (de) 1990-01-02 1990-12-12 Quinazolinderivate und ihre herstellung.

Country Status (14)

Country Link
US (1) US5264438A (de)
EP (1) EP0436157B1 (de)
JP (1) JPH0578349A (de)
KR (1) KR910014368A (de)
CN (1) CN1053063A (de)
AT (1) ATE126796T1 (de)
AU (1) AU635099B2 (de)
CA (1) CA2033363A1 (de)
DE (1) DE69021855T2 (de)
FI (1) FI906425L (de)
HU (1) HU208131B (de)
IE (1) IE904580A1 (de)
NO (1) NO905620L (de)
PT (1) PT96404A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes
CA2117075A1 (en) * 1991-09-06 1993-03-18 Norihiko Shimazaki Quinazoline derivatives and their preparation
GB9127532D0 (en) * 1991-12-31 1992-02-19 Fujisawa Pharmaceutical Co A novel use of a quinazoline derivative
GB9205702D0 (en) * 1992-03-16 1992-04-29 Fujisawa Pharmaceutical Co A new use of a quinazoline derivative
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
AU1618697A (en) * 1996-02-06 1997-08-28 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
WO1998033792A1 (en) * 1997-01-31 1998-08-06 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
US6521630B1 (en) * 1999-08-31 2003-02-18 Pfizer Inc. Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
DE102004020908A1 (de) * 2004-04-28 2005-11-17 Grünenthal GmbH Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
WO2007032572A1 (en) * 2005-09-15 2007-03-22 Korea Reserach Institute Of Chemical Technology N-substituted-1h-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same
JP2009542628A (ja) * 2006-07-05 2009-12-03 コーリア リサーチ インスティテュート オブ ケミカル テクノロジー 新規な置換−１ｈ−キナゾリン−２，４−ジオン誘導体、その製造方法及びそれを含む薬学的組成物
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
CN103739596A (zh) * 2013-12-10 2014-04-23 刘磊 用于心脑血管疾病的喹唑啉衍生物
CN106146413B (zh) * 2015-04-03 2019-01-18 中南大学 2,4-(1h,3h)-喹唑啉二酮衍生物及其合成方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274194A (en) * 1963-03-29 1966-09-20 Miles Lab Quinazolinedione derivatives
US4684654A (en) * 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
IE913473A1 (en) * 1990-10-15 1992-04-22 Fujisawa Pharmaceutical Co Quinazoline derivatives and their preparation

Also Published As

Publication number Publication date
HUT56089A (en) 1991-07-29
HU208131B (en) 1993-08-30
FI906425A7 (fi) 1991-07-03
NO905620L (no) 1991-07-03
CA2033363A1 (en) 1991-07-03
US5264438A (en) 1993-11-23
PT96404A (pt) 1991-10-15
FI906425A0 (fi) 1990-12-28
EP0436157B1 (de) 1995-08-23
AU635099B2 (en) 1993-03-11
JPH0578349A (ja) 1993-03-30
KR910014368A (ko) 1991-08-31
CN1053063A (zh) 1991-07-17
IE904580A1 (en) 1991-07-03
DE69021855D1 (de) 1995-09-28
AU6820790A (en) 1991-07-04
FI906425L (fi) 1991-07-03
DE69021855T2 (de) 1996-02-29
NO905620D0 (no) 1990-12-28
EP0436157A1 (de) 1991-07-10

Similar Documents

Publication Publication Date Title
DK459086A (da) Quinazolinderivater
PT98358A (pt) Processo para a preparacao de novos compostos pirazolopiridinicos
DK0622361T3 (da) Heterocykliske forbindelser som bradykininantagonister
FI890689A0 (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
NO905572D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
NO903438L (no) Fremgangsmaate for fremstilling av tiazolderivater.
ATE126796T1 (de) Quinazolinderivate und ihre herstellung.
FI895139A0 (fi) Pyrrolidinderivat.
EP0452809A3 (en) A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties